Roswitha Uibeleisen
Klinikum Stuttgart(DE)
Publications by Year
Research Areas
Hedgehog Signaling Pathway Studies, Genomic variations and chromosomal abnormalities, Acute Myeloid Leukemia Research, Lymphoma Diagnosis and Treatment, Cancer-related Molecular Pathways
Most-Cited Works
- → Expression of Hedgehog Pathway Mediator GLI Represents a Negative Prognostic Marker in Human Acute Myeloid Leukemia and Its Inhibition Exerts Antileukemic Effects(2015)103 cited
- → Age-adjusted high-dose chemotherapy followed by autologous stem cell transplantation or conventional chemotherapy with R-MP as first-line treatment in elderly primary CNS lymphoma patients – the randomized phase III PRIMA-CNS trial(2023)9 cited
- → Age-adjusted high-dose chemotherapy followed by autologous stem cell transplantation or conventional chemotherapy with R-MP as first- line treatment in elderly primary CNS lymphoma patients – the randomized phase III PRIMA-CNS trial(2023)1 cited
- → Supplemental Methods from Expression of Hedgehog Pathway Mediator <i>GLI</i> Represents a Negative Prognostic Marker in Human Acute Myeloid Leukemia and Its Inhibition Exerts Antileukemic Effects(2023)
- → Role of Geriatric Assessment Scores as Predictors of Intensive Therapy Feasibility and Survival in Elderly Patients with Primary CNS Lymphoma(2025)
- → Data from Expression of Hedgehog Pathway Mediator <i>GLI</i> Represents a Negative Prognostic Marker in Human Acute Myeloid Leukemia and Its Inhibition Exerts Antileukemic Effects(2023)
- → Supplemental Figures 1-6 from Expression of Hedgehog Pathway Mediator <i>GLI</i> Represents a Negative Prognostic Marker in Human Acute Myeloid Leukemia and Its Inhibition Exerts Antileukemic Effects(2023)
- → Supplemental Tables 1-4 from Expression of Hedgehog Pathway Mediator <i>GLI</i> Represents a Negative Prognostic Marker in Human Acute Myeloid Leukemia and Its Inhibition Exerts Antileukemic Effects(2023)